Polycystic Kidney Disease: Translating Mechanisms into Therapy
Editat de Benjamin D. Cowley, Jr., John J. Bissleren Limba Engleză Hardback – 25 mai 2018
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 158.41 lei 2 zile | |
Springer – 25 iul 2019 | 158.41 lei 2 zile | |
Hardback (1) | 760.99 lei 6-8 săpt. | |
Springer – 25 mai 2018 | 760.99 lei 6-8 săpt. |
Preț: 760.99 lei
Preț vechi: 801.03 lei
-5% Nou
Puncte Express: 1141
Preț estimativ în valută:
145.64€ • 153.65$ • 121.37£
145.64€ • 153.65$ • 121.37£
Carte tipărită la comandă
Livrare economică 02-16 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781493977826
ISBN-10: 1493977822
Pagini: 271
Ilustrații: XIII, 273 p. 62 illus., 42 illus. in color.
Dimensiuni: 178 x 254 mm
Greutate: 0.72 kg
Ediția:1st ed. 2018
Editura: Springer
Colecția Springer
Locul publicării:New York, NY, United States
ISBN-10: 1493977822
Pagini: 271
Ilustrații: XIII, 273 p. 62 illus., 42 illus. in color.
Dimensiuni: 178 x 254 mm
Greutate: 0.72 kg
Ediția:1st ed. 2018
Editura: Springer
Colecția Springer
Locul publicării:New York, NY, United States
Cuprins
PART 1. POLYCYSTIC KIDNEY DISEASE GENES & PROTEINS.- 1. Classical Polycystic Kidney Disease (PKD): Gene Structures and Mutations and Protein Structures and Functions.- 2. Bardet-Biedl Syndrome.- 3. Cystic Kidney Diseases Associated with Increased Cancer Risk: Tuberous Sclerosis Complex, Von Hippel Lindau, and Birt Hogg Dubé.- PART 2. POLYCYCSTIC KIDNEY DISEASE: MECHANISMS OF DISEASE.- 4. Aberrant Cellular Pathways in PKD.- 5. Cilia and Polycystic Kidney Disease.- 6. The Role of Inflammation and Fibrosis in Cystic Kidney Disease.- PART 3. CLINICAL FEATURES.- 7. Imaging-based Diagnosis of Autosomal Dominant Polycystic Kidney Disease.- 8. Renal Structural Involvement in Autosomal Dominant Polycystic Kidney Disease: Cyst Growth and Total Kidney Volume: Lessons from the Consortium for Radiologic Imaging of Polycystic Kidney Disease (CRISP).- 9. Renal Complications: Pain, Infection and Nephrolithiasis.- 10. ADPKD Extrarenal Manifestations: Polycystic Liver Disease.- 11. Extrarenal Manifestations of Autosomal Dominant Polycystic Kidney Disease.- PART 4. CLINICAL TRIALS AND EMERGING THERAPIES.- 12. Role of Renin- Angiotensin- Aldosterone System Inhibition in Autosomal Dominant Polycystic Kidney Disease.- 13. Vasopressin Receptor Antagonism.- 14. End-stage Renal Disease in Patients with Autosomal Dominant Polycystic Kidney Disease.- 15. Polycystic Kidney Disease: Translating Mechanisms into Therapy Management of ADPKD Today.
Notă biografică
John J. Bissler, MD
Federal Express Chair of Excellence, Professor and Chief, Division of Nephrology, Department of Pediatrics, Director of the Tuberous Sclerosis Center of Excellence at Le Bonheur Children’s Hospital, Medical Director of Nephrology, St. Jude Children's Research Hospital, University of Tennessee Health Science Center
University of Tennessee Health Science Center
Children’s Foundation Research Center
Memphis, TN
Benjamin D. Cowley, Jr., M.D., F.A.C.P., F.A.S.N.
Professor of Medicine
Chief, Nephrology & Hypertension
John Gammill Professor in Polycystic Kidney Disease
University of Oklahoma Health Sciences Center
Oklahoma City, OK
Federal Express Chair of Excellence, Professor and Chief, Division of Nephrology, Department of Pediatrics, Director of the Tuberous Sclerosis Center of Excellence at Le Bonheur Children’s Hospital, Medical Director of Nephrology, St. Jude Children's Research Hospital, University of Tennessee Health Science Center
University of Tennessee Health Science Center
Children’s Foundation Research Center
Memphis, TN
Benjamin D. Cowley, Jr., M.D., F.A.C.P., F.A.S.N.
Professor of Medicine
Chief, Nephrology & Hypertension
John Gammill Professor in Polycystic Kidney Disease
University of Oklahoma Health Sciences Center
Oklahoma City, OK
Textul de pe ultima copertă
This comprehensive guide to polycystic kidney disease captures the growing knowledge of this common, potentially-fatal and hereditary disease. The first two sections of the book provide an overview of PKD gene structures, mutations and pathophysiologic mechanisms. This is followed by chapters focused on PKD’s clinical features, including renal and extrarenal manifestations, and appropriate management of patients. The final section covers current clinical trials and emerging therapies in PKD. Authored by experts in the field, this book provides the clinician and researcher with critical information on basic and translational science and clinical approaches in one concise resource.
Caracteristici
Provides a comprehensive review of PKD mutations, pathophysiologic mechanisms of PKD, renal and extrarenal manifestations of PKD, clinical trials and emerging therapies in PKD, and appropriate management of patients with PKD Written by top professionals in the field Well-illustrated resource serves both clinician and researcher